The following is a summary of “Local molecular signature of human peripheral neuropathic pain,” published in the November ...

Leerink Partners analyst Mike Kratky maintained a Buy rating on AxoGen (AXGN – Research Report) on November 25 and set a price target of $0.00.

Scientists examine the effectiveness of an antibody targeting cell adhesion molecule 1 in alleviating pain-induced neuronal activation. Cell surface proteins are essential for facilitating cell ...

Discover various promising treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.

Its Remplir product is used in the repair of peripheral nerve injuries, where the global market is estimated to exceed ...

Mayor Mike McCormick, leading Godfrey since 2009, aims for re-election in 2025 despite battling peripheral neuropathy.

A memorial tribute to Broadway star Gavin Creel will be held next Monday in the theater where he starred in “Into the Woods.” ...

Eagle Asset Management Inc. bought a new stake in AxoGen, Inc. (NASDAQ:AXGN – Free Report) in the third quarter, according to ...

When Renerve makes its IPO on the ASX today, it will join Orthocell as one of only two nerve-repair companies to be listed on ...

An international team of researchers has discovered a new component of the peripheral nervous system that acts by increasing energy metabolism in the body.

Development of neuropathic pain in those with long COVID is believed to result from increased cytokine proliferation mediated by angiotensin-converting enzyme 2, which enables the virus to enter into ...